Breast Cancer Clinical Trial
Official title:
Evaluation of Postcard Mailers Enhanced With Behavioral Nudges to Promote Mammogram Screening
Verified date | November 2021 |
Source | Geisinger Clinic |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
In this evaluation, 3 different versions of mailers promoting annual mammograms are being sent to women on the month of their 50th and 64th birthdays. The researchers hypothesize that the use of behavioral nudges in the mailers should lead to increased uptake in mammogram screening.
Status | Completed |
Enrollment | 1342 |
Est. completion date | October 5, 2021 |
Est. primary completion date | October 5, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 50 Years to 64 Years |
Eligibility | Inclusion Criteria: - Female Geisinger Health Plan members turning 50 and 64 in that month - For the 2020 campaign, birthdays from June 2020 (as opposed to August 2020) will be included due to a temporary suspension of the outreach program due to the COVID-19 pandemic since June - For the pre-post examination of the 2019 campaign, all months in that year will be included Exclusion Criteria: - Members who are on the do not contact list at Geisinger Health Plan |
Country | Name | City | State |
---|---|---|---|
United States | Geisinger | Danville | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Geisinger Clinic |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Mammogram Completion at 12 months (2019) | Binary variable indicating whether a mammogram was completed to be used for exploratory pre-post comparisons | 12 months from 2019 intervention start date | |
Other | Primary Care Provider Visits at 12 months (2019) | Number of visits to be used for exploratory pre-post comparisons (proxy for increased preventative health care) | 12 months from 2019 intervention start date | |
Other | Breast Cancer Diagnosis at 12 months (2019) | Binary variable indicating whether the woman was diagnosed with breast cancer | 12 months from 2019 intervention start date | |
Other | Emergency Department Visits at 12 months (2019) | Number of Emergency Department Visits (proxy for increased costly utilization of health system resources) | 12 months from 2019 intervention start date | |
Primary | Mammogram Completion at 6 months (2020) | Binary variable indicating whether a mammogram was completed | 6 months from intervention start date | |
Secondary | Mammogram Completion at 12 months (2020) | Binary variable indicating whether a mammogram was completed (a longer time frame allows for late responses) | 12 months from intervention start date | |
Secondary | Primary Care Provider Visits at 6 months (2020) | Number of visits (proxy for increased preventative health care) | 6 months from intervention start date | |
Secondary | Primary Care Provider Visits at 12 months (2020) | Number of visits (proxy for increased preventative health care) | 12 months from intervention start date | |
Secondary | Obstetrician-Gynecologist Visits at 6 months (2020) | Number of visits (proxy for increased preventative health care) | 6 months from intervention start date | |
Secondary | Obstetrician-Gynecologist Visits at 12 months (2020) | Number of visits (proxy for increased preventative health care) | 12 months from intervention start date | |
Secondary | Breast Cancer Diagnosis at 6 months (2020) | Binary variable indicating whether the recipient was diagnosed with breast cancer | 6 months from intervention start date | |
Secondary | Breast Cancer Diagnosis at 12 months (2020) | Binary variable indicating whether the recipient was diagnosed with breast cancer | 12 months from intervention start date | |
Secondary | Emergency Department Visits at 6 months (2020) | Number of Emergency Department Visits (proxy for increased costly utilization of health system resources) | 6 months from intervention start date | |
Secondary | Emergency Department Visits at 12 months (2020) | Number of Emergency Department Visits (proxy for increased costly utilization of health system resources) | 12 months from intervention start date |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Recruiting |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |